AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

PCSA · NASDAQ · Biotechnology

Processa Pharmaceuticals (PCSA)

Develops altered-metabolism cancer therapies from in-licensed cytotoxic drugs.

$2.09

At close+0.04 (+1.95%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Insiders10 holders · as of Aug 11, 2026	3.76%	105.0K shares
Strategic holders1 holder · as of Feb 23, 2026	10.94%	305.6K shares
Otherremainder	85.30%	2.38M shares

2.79M company shares as of Sep 3, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
HX Entertainment LtdStrategic	10.94%	305,644	13Dfiled Feb 23, 2026 ↗
Soleus Capital Master Fund, L.P.Institution	5.76%	160,943	13Gfiled Aug 18, 2026 ↗
George K. NgInsiderdirector, officer: Chief Executive Officer	0.83%	23,112	Form 4filed Aug 11, 2026 ↗
David YoungInsiderdirector, officer: Pres. Research & Development	0.78%	21,729	Form 4filed Jul 1, 2026 ↗
Russell SkibstedInsiderofficer: Chief Financial Officer	0.60%	16,689	Form 4filed Jul 1, 2026 ↗
Patrick LinInsiderofficer: Chief Business - Strategy Off	0.53%	14,853	Form 4filed Jul 1, 2026 ↗
Wendy GuyInsiderofficer: Chief Administrative Officer	0.52%	14,394	Form 4filed Jul 1, 2026 ↗
Sian BigoraInsiderofficer: Chief Development Officer	0.27%	7,481	Form 4filed May 19, 2026 ↗
Khoso BaluchInsiderdirector	0.09%	2,528	Form 4filed Jun 30, 2026 ↗
Geraldine PannuInsiderdirector	0.09%	2,391	Form 4filed Jun 30, 2026 ↗
James R. NealInsiderdirector	0.04%	1,021	Form 4filed Jun 30, 2026 ↗
Justin W. YorkeInsiderdirector	0.03%	849	Form 4filed Jun 30, 2026 ↗
CVI Investments, Inc.Strategic	—9.00% of class, as filed	—	13Gfiled Nov 7, 2025 ↗
Chiliz Group Ltd.Strategic	—10.90% of class, as filed	—	13Dfiled Oct 15, 2025 ↗
Concert Pharmaceuticals, Inc.Strategic	—5.90% of class, as filed	—	13Gfiled Mar 22, 2018 ↗
Manchester Management Company, LLCStrategic	—0.90% of class, as filed	—	13G/Afiled Aug 10, 2021 ↗
Mitchell P. KopinInsider	—9.99% of class, as filed	—	13Gfiled Aug 12, 2025 ↗
Yuhan (USA) CorporationStrategic	—7.30% of class, as filed	—	13Gfiled Jun 11, 2021 ↗
James E. Besser¹Insider10 percent owner	0.05%	1,297	Form 4filed May 5, 2021 ↗
James H. Stanker²Insiderofficer: Chief Financial Officer	0.01%	259	Form 4filed Aug 2, 2024 ↗
Virgil Thompson³Insiderdirector	0.01%	203	Form 4filed Jul 24, 2023 ↗
Robert Michael Floyd⁴Insiderofficer: Chief Operating Officer	0.01%	165	Form 4filed Feb 10, 2023 ↗
Khalid Islam⁵Insiderdirector	0.00%	36	Form 4filed Apr 19, 2022 ↗

Last filed May 5, 2021; leaving the company requires no filing. Not in the bar.
Last filed Aug 2, 2024; leaving the company requires no filing. Not in the bar.
Last filed Jul 24, 2023; leaving the company requires no filing. Not in the bar.
Last filed Feb 10, 2023; leaving the company requires no filing. Not in the bar.
Last filed Apr 19, 2022; leaving the company requires no filing. Not in the bar.

13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F

No 13F holders on record.

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
HX Entertainment Ltd	13.00%	305.6K	13D	Feb 23, 2026 ↗
Chiliz Group Ltd.	10.90%		13D	Oct 15, 2025 ↗
Mitchell P. Kopin	9.99%		13G	Aug 12, 2025 ↗
CVI Investments, Inc.	9.00%		13G	Nov 7, 2025 ↗
Soleus Capital Master Fund, L.P.	5.80%	160.9K	13G	Aug 18, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Jun 30, 2026	David Youngdirector, officer: Pres. Research & Development	Purchase	2,531	$1.93	21,729
Jun 30, 2026	Russell Skibstedofficer: Chief Financial Officer	Purchase	3,277	$1.93	16,689
Jul 1, 2026	George K. Ngdirector, officer: Chief Executive Officer	Purchase	3,057	$1.93	15,492
Jun 30, 2026	Patrick Linofficer: Chief Business - Strategy Off	Purchase	2,106	$1.93	13,113
Jun 30, 2026	Wendy Guyofficer: Chief Administrative Officer	Purchase	2,436	$1.93	14,394
Jun 15, 2026	Wendy Guyofficer: Chief Administrative Officer	Purchase	2,118	$2.22	11,958
Jun 15, 2026	Patrick Linofficer: Chief Business - Strategy Off	Purchase	1,831	$2.22	11,007
Jun 15, 2026	George K. Ngdirector, officer: Chief Executive Officer	Purchase	2,465	$2.22	12,435
Jun 15, 2026	Russell Skibstedofficer: Chief Financial Officer	Purchase	2,654	$2.22	13,412
Jun 15, 2026	David Youngdirector, officer: Pres. Research & Development	Purchase	2,067	$2.22	19,198

CongressHouse and Senate disclosures

Not reported.